State Street’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.17M Buy
2,475,648
+1,839,451
+289% +$3.62M ﹤0.01% 2997
2026
Q1
$1.11M Sell
636,197
-7,800
-1% -$14.2K ﹤0.01% 3463
2025
Q4
$1.51M Buy
+643,997
New +$1.24M ﹤0.01% 3418
2024
Q2
Sell
-1,498
Closed -$8.96K 4385
2024
Q1
$8.96K Hold
1,498
﹤0.01% 4331
2023
Q4
$13.3K Hold
1,498
﹤0.01% 4377
2023
Q3
$13.1K Hold
1,498
﹤0.01% 4484
2023
Q2
$38.2K Buy
+1,498
New +$37.4K ﹤0.01% 4484
2022
Q4
Sell
-38
Closed -$3K 4886
2022
Q3
$3K Hold
38
﹤0.01% 4926
2022
Q2
$12K Hold
38
﹤0.01% 4913
2022
Q1
$30K Hold
38
﹤0.01% 4862
2021
Q4
$37K Hold
38
﹤0.01% 4741
2021
Q3
$75K Hold
38
﹤0.01% 4601
2021
Q2
$115K Buy
+38
New +$172K ﹤0.01% 4333
2017
Q1
Hold
0
-$12K 3666
2016
Q4
Hold
0
3634
2016
Q3
Hold
0
3562
2016
Q2
Hold
0
3691
2016
Q1
Hold
0
3598
2015
Q4
Hold
0
3556
2015
Q3
Hold
0
3537
2015
Q2
Sell
-1
Closed -$2.18M 3499
2015
Q1
$1.68M Hold
1
﹤0.01% 3085
2014
Q4
$2.16M Hold
1
﹤0.01% 3013
2014
Q3
$2.46M Hold
1
﹤0.01% 2905
2014
Q2
$2.75M Buy
+1
New +$4.7M ﹤0.01% 2905
2014
Q1
Hold
0
3477
2013
Q4
Hold
0
3495
2013
Q3
Hold
0
3482
2013
Q2
Hold
0
3459

Other funds holding PALI

State Street's PALI Position: Q2 2026 in Review

State Street increased its Palisade Bio (PALI) stake by 289% in Q2 2026, buying an estimated $3.62M and bringing the position to 2,475,648 shares worth $5.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2997.

State Street first reported a position in PALI in Q2 2014 and has held it in 17 quarters since. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • State Street held 2,475,648 shares of Palisade Bio worth $5.17M as of Q2 2026.
  • State Street bought 1,839,451 Palisade Bio shares in Q2 2026, an estimated $3.62M.
  • Palisade Bio made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2997 holding.
  • State Street first reported a position in Palisade Bio in Q2 2014 and has held it in 17 quarters since.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.